Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic variation effects on dexmedetomidine metabolism and clinical effects
ChiCTR1800017474Phase 4Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine, sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Sedation effect. Started Aug 2018; status: recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on ChiCTR1800017474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017474.